Preoperative Risk Factors for Lymphedema in Inflammatory Breast Cancer
Journal of Reconstructive Microsurgery · 01.05.2024 · 40 (04) · 311-317
DOI: 10.1055/a-2182-1015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Reconstructive Microsurgery, erschienen am 01.05.2024. Verfasst von Libby R Copeland-Halperin und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Northwell Health, New York, New York. Hauptthemen laut MEDLINE: Breast Neoplasms, Inflammatory Breast Neoplasms, Lymphedema. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben.
Abstract (Originalsprache)
Background
Prophylactic lymphatic bypass or LYMPHA (LYmphatic Microsurgical Preventive Healing Approach) is increasingly offered to prevent lymphedema following breast cancer treatment, which develops in up to 47% of patients. Previous studies focused on intraoperative and postoperative lymphedema risk factors, which are often unknown preoperatively when the decision to perform LYMPHA is made. This study aims to identify preoperative lymphedema risk factors in the high-risk inflammatory breast cancer (IBC) population.
Methods
Retrospective review of our institution's IBC program database was conducted. The primary outcome was self-reported lymphedema development. Multivariable logistic regression analysis was performed to identify preoperative lymphedema risk factors, while controlling for number of lymph nodes removed during axillary lymph node dissection (ALND), number of positive lymph nodes, residual disease on pathology, and need for adjuvant chemotherapy.
Results
Of 356 patients with IBC, 134 (mean age: 51 years, range: 22–89 years) had complete data. All 134 patients underwent surgery and radiation. Forty-seven percent of all 356 patients (167/356) developed lymphedema. Obesity (body mass index > 30) (odds ratio [OR]: 2.7, confidence interval [CI]: 1.2–6.4, p = 0.02) and non-white race (OR: 4.5, CI: 1.2–23, p = 0.04) were preoperative lymphedema risk factors.
Conclusion
Patients with IBC are high risk for developing lymphedema due to the need for ALND, radiation, and neoadjuvant chemotherapy. This study also identified non-white race and obesity as risk factors. Larger prospective studies should evaluate potential racial disparities in lymphedema development. Due to the high prevalence of lymphedema, LYMPHA should be considered for all patients with IBC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Surgery, Northwell Health, New York, New York.
- Department of Surgery, Mass General Brigham, Boston, Massachusetts.
- Harvard Medical School, Boston, Massachusetts.
- Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
- Department of Medicine, Dana-Farber Cancer Institute, Boston, Massachusetts.
- Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts.
ORCID-Profile: Libby R Copeland-Halperin
Zitieren
APA
Copeland-Halperin, L. R., Hyland, C. J., Gadiraju, G. K., Xiang, D. H., Bellon, J. R., Lynce, F., Dey, T., Troll, E. P., Ryan, S. J., Nakhlis, F., & Broyles, J. M. (2024). Preoperative Risk Factors for Lymphedema in Inflammatory Breast Cancer. Journal of Reconstructive Microsurgery, 40(04), 311-317. https://doi.org/10.1055/a-2182-1015
Vancouver
Copeland-Halperin LR, Hyland CJ, Gadiraju GK, Xiang DH, Bellon JR, Lynce F, et al. Preoperative Risk Factors for Lymphedema in Inflammatory Breast Cancer. Journal of Reconstructive Microsurgery. 2024;40(04):311-317. doi:10.1055/a-2182-1015
BibTeX
@article{CopelandHalperin2024,
author = {Copeland-Halperin, Libby R and Hyland, Colby J and Gadiraju, Goutam K and Xiang, David H and Bellon, Jennifer R and Lynce, Filipa and Dey, Tanujit and Troll, Elizabeth P and Ryan, Sean J and Nakhlis, Faina and Broyles, Justin M},
title = {Preoperative Risk Factors for Lymphedema in Inflammatory Breast Cancer},
journal = {Journal of Reconstructive Microsurgery},
year = {2024},
volume = {40},
number = {04},
pages = {311--317},
doi = {10.1055/a-2182-1015}
}
EUVIMED